Advanced search
Publication Cover
Scandinavian Journal of Infectious Diseases Volume 36, 2004 - Issue 3
Submit an article Journal homepage
27
Views
9
CrossRef citations to date
0
Altmetric
Original Paper

Serum ALT Levels as a Surrogate Marker for Serum HBV DNA Levels in HBeAg-negative Pregnant Women

Per Sangfelt Department of Medical Sciences, Section of Infectious Diseases, Akademiska Hospital, UppsalaCorrespondence[email protected]
,
Madeleine Von Sydow Department of Virology, Karolinska Hospital, Stockholm
,
Ingrid Uhnoo Infectious Diseases, Huddinge University Hospital, Stockholm
,
Ola Weiland Paediatrics, Huddinge University Hospital, Stockholm
,
Gudrun Lindh Obstetrics and Gynaecology, Huddinge University Hospital, Stockholm
,
Björn Fischler Department of Infectious Diseases, Karolinska Hospital, Uppsala University, Uppsala and Karolinska Institute, Stockholm
,
Susanne Lindgren Department of Medical Sciences, Section of Infectious Diseases, Akademiska Hospital, Uppsala
&
Olle Reichard Department of Virology, Karolinska Hospital, Stockholm
 show all
Pages 182-185 | Received 11 Dec 2003, Accepted 19 Jan 2004, Published online: 08 Jul 2009

  • Stevens CE, Beasley RP, Tsui J, Lee WC. Vertical transmission of hepatitis B antigen in Taiwan. N Engl J Med 1975; 292(15): 771–4.
  • Beasley RP, Hwang LY, Lee GC, Lan CC, Roan CH, Huang FY, Chen CL. Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B immune globulin and hepatitis B vaccine. Lancet 1983; 2(8359): 1099–102.
  • Ip HM, Lelie PN, Wong VC, Kuhns MC, Reesink HW. Prevention of hepatitis B virus carrier state in infants according to maternal serum levels of HBV DNA. Lancet 1989; 1(8635): 406–10.
  • del Canho R, Grosheide PM, Schalm SW, de Vries RR, Heijtink RA. Failure of neonatal hepatitis B vaccination: the role of HBV DNA levels in hepatitis B carrier mothers and HLA antigens in neonates. J Hepatol 1994; 20(4): 483–6.
  • Burk RD, Hwang LY, Ho GY, Shafritz DA, Beasley RP Outcome of perinatal hepatitis B virus exposure is dependent on maternal virus load. J Infect Dis 1994; 170(6): 1418–23.
  • del Canho R, Grosheide PM, Mazel JA, Heijtink RA, Hop WC, Gerards LJ, et al. 10-y neonatal hepatitis B vaccination programme, The Netherlands, 1982–1992: protective efficacy and long-term immunogenicity. Vaccine 1997; 15(15): 1624–30.
  • Hadziyannis S. Hepatitis B e antigen-negative chronic hepatitis B: from clinical recognition to pathogenesis and treatment. Viral Hepat Rev 1995; 1: 7–36.
  • Funk ML, Rosenberg DM, Lok AS. Worldwide epidemiology of HBeAg-negative chronic hepatitis B and associated precore and core promoter variants. J Viral Hepat 2002; 9(1): 52–61.
  • Lindh M, Horal P, Dhillon AP, Norkrans G. Hepatitis B virus DNA levels, precore mutations, genotypes and histological activity in chronic hepatitis B. J Viral Hepat 2000; 7(4): 258–67.
  • Chu CJ, Keeffe EB, Han SH, Perrillo RP, Min AD, SoldevilaPico C, et al. Prevalence of HBV precore/core promoter variants in the United States. Hepatology 2003; 38(3): 619–28.
  • Bacq Y, Zarka O, Brechot JF, Mariotte N, Vol S, Tichet J, Weill J. Liver function tests in normal pregnancy: a prospective study of 103 pregnant women and 103 matched controls. Hepatology 1996; 23(5): 1030–4.
  • Chu CJ, Hussain M, Lok AS. Quantitative serum HBV DNA levels during different stages of chronic hepatitis B infection. Hepatology 2002; 36(6): 1408–15.
  • Soderstrom A, Norkrans G, Lindh M. Hepatitis B virus DNA during pregnancy and post partum: aspects on vertical transmission. Scand J Infect Dis 2003; 35(11–12): 817–9.
  • WHO. WHO expanded programme on immunization. Report of 14th Global Advisory Group. Antalya, Turkey; 1991 Oct 14–18.
  • Iwarson S. Why the Scandinavian countries have not implemented universal vaccination against hepatitis B. Vaccine 1998; 16 (Suppl): S56–7.
  • Beasley RP, Hwang LY, Lin CC, Stevens CE, Wang KY, Sun TS, et al. Hepatitis B immune globulin (HBIG) efficacy in the interruption of perinatal transmission of hepatitis B virus carrier state. Initial report of a randomized double-blind placebocontrolled trial. Lancet 1981; 2(8243): 388–93.
  • Lok AS, Heathcote EJ, Hoofnagle JH. Management of hepatitis B: 2000: summary of a workshop. Gastroenterology 2001; 120(7): 1828–53.
  • Rosendahl C, Kochen MM, Kretschmer R, Wegscheider K, Kaiser D. Avoidance of perinatal transmission of hepatitis B virus: is passive immunization always necessary? Lancet 1983; 1(8334): 1127–9.
  • Esteban JI, Genesca J, Esteban R, Hernandez JM, Seijo G, Buti M, et al. Immunoprophylaxis of perinatal transmission of the hepatitis B virus: efficacy of hepatitis B immune globulin and hepatitis B vaccine in a low-prevalence area. J Med Virol 1986; 18(4): 381–91.
  • Milne A, West DJ, Chinh DV, Moyes CD, Poerschke G. Field evaluation of the efficacy and immunogenicity of recombinant hepatitis B vaccine without HBIG in newborn Vietnamese infants. J Med Virol 2002; 67(3): 327–33.
  • Yang YJ, Liu CC, Chen TJ, Lee MF, Chen SH, Shih HH, Chang MH. Role of hepatitis B immunoglobulin in infants born to hepatitis B e antigen-negative carrier mothers in Taiwan. Pediatr Infect Dis J 2003; 22(7): 584–8.
  • Sangfelt P, Reichard O, Lidman K, von Sydow M, Forsgren M. Prevention of hepatitis B by immunization of the newborn infant: a longterm follow-up study in Stockholm, Sweden. Scand J Infect Dis 1995; 27(1): 3–7.
  • Soderstrom A, Norkrans G, Conradi N, Krantz M, Horal P, Lindh M. Histological activity of childhood chronic hepatitis B related to viraemia levels, genotypes, mutations, and epidemiological factors. J Pediatr Gastroenterol Nutr 2002; 35(4): 487–94.
  • ACIP Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination. Recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR 1991; 40: 1–19.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.